Zehni, A.Z.; Batz, F.; Vattai, A.; Kaltofen, T.; Schrader, S.; Jacob, S.-N.; Mumm, J.-N.; Heidegger, H.H.; Ditsch, N.; Mahner, S.;
et al. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer. Int. J. Mol. Sci. 2021, 22, 957.
https://doi.org/10.3390/ijms22020957
AMA Style
Zehni AZ, Batz F, Vattai A, Kaltofen T, Schrader S, Jacob S-N, Mumm J-N, Heidegger HH, Ditsch N, Mahner S,
et al. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer. International Journal of Molecular Sciences. 2021; 22(2):957.
https://doi.org/10.3390/ijms22020957
Chicago/Turabian Style
Zehni, Alaleh Zati, Falk Batz, Aurelia Vattai, Till Kaltofen, Svenja Schrader, Sven-Niclas Jacob, Jan-Niclas Mumm, Helene Hildegard Heidegger, Nina Ditsch, Sven Mahner,
and et al. 2021. "The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer" International Journal of Molecular Sciences 22, no. 2: 957.
https://doi.org/10.3390/ijms22020957
APA Style
Zehni, A. Z., Batz, F., Vattai, A., Kaltofen, T., Schrader, S., Jacob, S.-N., Mumm, J.-N., Heidegger, H. H., Ditsch, N., Mahner, S., Jeschke, U., & Vilsmaier, T.
(2021). The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer. International Journal of Molecular Sciences, 22(2), 957.
https://doi.org/10.3390/ijms22020957
